Chemical Compound Review:
Anabaseine 3-(3,4,5,6-tetrahydropyridin- 2-yl)pyridine
Synonyms:
SureCN261062, AG-A-96241, LS-44635, CTK8F7764, ZINC14722833, ...
Papke,
Meyer,
Lavieri,
Bollampally,
Papke,
Horenstein,
Itoh,
Porter Papke,
Kem,
van Westerloo,
Giebelen,
Florquin,
Bruno,
Larosa,
Ulloa,
Tracey,
van der Poll,
- The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. van Westerloo, D.J., Giebelen, I.A., Florquin, S., Bruno, M.J., Larosa, G.J., Ulloa, L., Tracey, K.J., van der Poll, T. Gastroenterology (2006)
- Relative toxicities and neuromuscular nicotinic receptor agonistic potencies of anabasine enantiomers and anabaseine. Lee, S.T., Wildeboer, K., Panter, K.E., Kem, W.R., Gardner, D.R., Molyneux, R.J., Chang, C.W., Soti, F., Pfister, J.A. Neurotoxicology and teratology. (2006)
- Selective alpha 7 nicotinic receptor stimulation normalizes chronic cocaine-induced loss of hippocampal sensory inhibition in C3H mice. Stevens, K.E., Kem, W.R., Freedman, R. Biol. Psychiatry (1999)
- Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes. de Fiebre, C.M., Meyer, E.M., Henry, J.C., Muraskin, S.I., Kem, W.R., Papke, R.L. Mol. Pharmacol. (1995)
- Effects at a distance in alpha 7 nAChR selective agonists: benzylidene substitutions that regulate potency and efficacy. Papke, R.L., Meyer, E.M., Lavieri, S., Bollampally, S.R., Papke, T.A., Horenstein, N.A., Itoh, Y., Porter Papke, J.K. Neuropharmacology (2004)
- Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells. Ridley, D.L., Rogers, A., Wonnacott, S. Br. J. Pharmacol. (2001)
- Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors. Kem, W.R., Mahnir, V.M., Papke, R.L., Lingle, C.J. J. Pharmacol. Exp. Ther. (1997)
- Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice. Simosky, J.K., Stevens, K.E., Kem, W.R., Freedman, R. Biol. Psychiatry (2001)
- Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist. Kem, W.R. Invert. Neurosci. (1997)
- Effects of nicotinic receptor agonists on beta-amyloid beta-sheet formation. Kihara, T., Shimohama, S., Akaike, A. Jpn. J. Pharmacol. (1999)